tiprankstipranks
Trending News
More News >
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
NASDAQ:GPCR
US Market
Advertisement

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership - Who Owns Structure Therapeutics, Inc. Sponsored ADR?

Compare
1,063 Followers

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership Overview

11.90%25.93%46.09%1.18%14.90%
11.90% Insiders
46.09% Other Institutional Investors
1.18% ETFs
14.90% Public Companies and Individual Investors
The ownership structure of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is a mix of institutional, retail, and individual investors. Approximately 73.20% of the company’s stock is owned by Institutional Investors, 11.90% is owned by Insiders, and 14.90% is owned by Public Companies and Individual Investors.
The ownership structure of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is a mix of institutional, retail, and individual investors. Approximately 72.02% of the company’s stock is owned by Institutional Investors, 11.90% is owned by Insiders, and 1.18% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$60809
Jun 30, 2025
xxxxxxxxxxxxx
$3659635
Jun 30, 2025
xxxxxxxxxxxxx
$13953706
Jun 30, 2025
xxxxxxxxxxxxx
$52031827

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,874,462Insider4.99%84,020,524
2,749,416Insider4.77%80,365,430
2,508,767Institution4.36%73,331,259
1,990,460Institution3.46%58,181,146
1,599,660Institution2.78%46,758,062
1,517,418Institution2.63%44,354,128
1,465,232Institution2.54%42,828,731
1,344,432Institution2.33%39,297,747
1,204,864Institution2.09%35,218,175
841,500Institution1.46%24,597,045

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,990,460Institution3.46%58,181,146
1,599,660Institution2.78%46,758,062
1,465,232Institution2.54%42,828,731
1,344,432Institution2.33%39,297,747
1,204,864Institution2.09%35,218,175
841,500Institution1.46%24,597,045
793,327Institution1.38%23,188,948
739,695Institution1.28%21,621,285
582,447Institution1.01%17,024,926
550,000Institution0.95%16,076,500

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
244,317Institution0.42%7,361,271
71,944Institution0.12%1,388,519
58,222Institution0.10%1,757,722
43,885Institution0.08%910,175
39,300Institution0.07%1,186,467
38,644Institution0.07%745,829
36,178Institution0.06%1,092,214
35,829Institution0.06%1,079,528
28,258Institution0.05%851,414
20,481Institution0.04%618,321

FAQ

Who Owns Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
According to the latest TipRanks data, approximately 46.09% of the company's stock is held by institutional investors, 11.90% is held by insiders, and 14.90% is held by retail investors.
    What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 46.09% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors.
      What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 14.90% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors.
        Who owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
        Jun Yoon owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis